These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34600036)

  • 1. Preparation of glycopolymers having sialyl α2 → 3 lactose moieties as the potent inhibitors for mumps virus.
    Matsuoka K; Kaneshima T; Adachi R; Sasaki J; Hashiguchi T; Koyama T; Matsushita T; Hatano K
    Bioorg Med Chem Lett; 2021 Nov; 52():128389. PubMed ID: 34600036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic construction of sugar-amino acid hybrid polymers involving globotriaose or lactose and evaluation of their biological activities against Shiga toxins produced by Escherichia coli O157:H7.
    Matsuoka K; Nishikawa K; Goshu Y; Koyama T; Hatano K; Matsushita T; Watanabe-Takahashi M; Natori Y; Terunuma D
    Bioorg Med Chem; 2018 Dec; 26(22):5792-5803. PubMed ID: 30420327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of Glycopolymers Carrying Sialyl Oligosaccharides for Controlling the Interaction with the Influenza Virus.
    Nagao M; Fujiwara Y; Matsubara T; Hoshino Y; Sato T; Miura Y
    Biomacromolecules; 2017 Dec; 18(12):4385-4392. PubMed ID: 29111681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a Longer Aglycon Moiety Bearing Sialyl α(2→3) Lactoside on the Glycopolymer for Lectin Evaluation.
    Adachi R; Matsushita T; Koyama T; Hatano K; Matsuoka K
    Polymers (Basel); 2023 Feb; 15(4):. PubMed ID: 36850281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic assembly of a series of glycopolymers having sialyl α2-3 lactose moieties connected with longer spacer arms.
    Adachi R; Matsushita T; Koyama T; Hatano K; Matsuoka K
    Bioorg Med Chem; 2023 Mar; 81():117209. PubMed ID: 36787684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of sialic acid derivatives containing a long hydrophobic chain at the anomeric position and their C-5 linked polymers as potent influenza virus inhibitors.
    Suzuki K; Koyama T; Yingsakmongkon S; Suzuki Y; Hatano K; Matsuoka K
    Bioorg Med Chem; 2012 Jan; 20(1):446-54. PubMed ID: 22100261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorogenic glycopolymers available for determining the affinity of lectins by intermolecular FRET.
    Matsuoka K; Suzuki Y; Koyama T; Matsushita T; Hatano K
    Bioorg Med Chem Lett; 2020 Apr; 30(8):127024. PubMed ID: 32098722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of sialic acid derivatives having a C=C double bond substituted at the C-5 position and their glycopolymers.
    Suzuki K; Sakamoto J; Koyama T; Yingsakmongkon S; Suzuki Y; Hatano K; Terunuma D; Matsuoka K
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5105-8. PubMed ID: 19631531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trisaccharide containing α2,3-linked sialic acid is a receptor for mumps virus.
    Kubota M; Takeuchi K; Watanabe S; Ohno S; Matsuoka R; Kohda D; Nakakita SI; Hiramatsu H; Suzuki Y; Nakayama T; Terada T; Shimizu K; Shimizu N; Shiroishi M; Yanagi Y; Hashiguchi T
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11579-11584. PubMed ID: 27671656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple synthesis of sialyllactose-carrying polystyrene and its binding with influenza virus.
    Tsuchida A; Kobayashi K; Matsubara N; Muramatsu T; Suzuki T; Suzuki Y
    Glycoconj J; 1998 Nov; 15(11):1047-54. PubMed ID: 10386889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of Various Glycopolymers Bearing Sialyllactose and the Effect of Their Molecular Mobility on Interaction with the Influenza Virus.
    Nagao M; Matsubara T; Hoshino Y; Sato T; Miura Y
    Biomacromolecules; 2019 Jul; 20(7):2763-2769. PubMed ID: 31199883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Mechanism of the Flexible Glycan Receptor Recognition by Mumps Virus.
    Kubota M; Matsuoka R; Suzuki T; Yonekura K; Yanagi Y; Hashiguchi T
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31118251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro study of antiviral activity of Myramistin against measles and mumps viruses].
    Agafonov AP; Ignat'ev GM; Svistov VV; Smirnov IV; Krivoshein IuS
    Antibiot Khimioter; 2005; 50(5-6):17-9. PubMed ID: 16526604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sialyl alpha(2-->3) lactose clusters using carbosilane dendrimer core scaffolds as influenza hemagglutinin blockers.
    Oka H; Onaga T; Koyama T; Guo CT; Suzuki Y; Esumi Y; Hatano K; Terunuma D; Matsuoka K
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4405-8. PubMed ID: 18639456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Ribavirin on Mumps Virus Population Diversity.
    Jurković M; Slović A; Forčić D; Ivančić-Jelečki J; Košutić-Gulija T; Jagušić M
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syntheses and biological evaluations of carbosilane dendrimers uniformly functionalized with sialyl alpha(2-->3) lactose moieties as inhibitors for human influenza viruses.
    Oka H; Onaga T; Koyama T; Guo CT; Suzuki Y; Esumi Y; Hatano K; Terunuma D; Matsuoka K
    Bioorg Med Chem; 2009 Aug; 17(15):5465-75. PubMed ID: 19589684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiosialoside-decorated polymers use a two-step mechanism to inhibit both early and late stages of influenza virus infection.
    Yu Y; Qin HJ; Shi XX; Song JQ; Zhou JP; Yu P; Fan ZC; Zhong M; Yang Y
    Eur J Med Chem; 2020 Aug; 199():112357. PubMed ID: 32428793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro inhibition of mumps virus replication by favipiravir (T-705).
    Lawson B; Suppiah S; Rota PA; Hickman CJ; Latner DR
    Antiviral Res; 2020 Aug; 180():104849. PubMed ID: 32553844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoenzymatic synthesis, characterization, and application of glycopolymers carrying lactosamine repeats as entry inhibitors against influenza virus infection.
    Hidari KI; Murata T; Yoshida K; Takahashi Y; Minamijima YH; Miwa Y; Adachi S; Ogata M; Usui T; Suzuki Y; Suzuki T
    Glycobiology; 2008 Oct; 18(10):779-88. PubMed ID: 18621993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of an Antiviral Component in Human Seminal Plasma.
    Chen R; Zhang W; Gong M; Wang F; Wu H; Liu W; Gao Y; Liu B; Chen S; Lu W; Yu X; Liu A; Han R; Chen Y; Han D
    Front Immunol; 2021; 12():580454. PubMed ID: 33679733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.